A research team at the University of Cologne has significantly advanced our understanding of Alzheimer’s disease by identifying a key variant of the tau protein, 1N4R, that contributes to neurodegenerative effects. This discovery was made using human induced pluripotent stem cells (iPSCs) and cutting-edge CRISPR/Cas9 gene editing technologies.
About the Author
